Following a protracted decline that began in 2007,  we expect global demand for laser refractive surgery to start improving in 2010 and to subsequently return to  previous levels and growth rates. However, much of the growth in the coming years will be driven by increasing demand in rapidly emerging markets, while recovery will be slower in the US and in Europe. 

Steady increases in ophthalmic surgeries and advances in surgical procedures and technologies are forecast to fuel healthy growth in the ophthalmic surgical instruments market over the next five years.  We expect much of this growth to occur in the disposable product segment, which is buoyed by increasing concerns about cross-contamination and has remained largely unaffected by the global recession.

Glaucoma and retinal diagnostic equipment generated nearly 50 percent of the revenues in the entire ophthalmic diagnostic equipment market in 2008. As populations age worldwide and as access to improved healthcare increases in many regions, markets for this specialized diagnostic equipment will grow, particularly in rapidly developing nations. New diagnostic technologies are also providing an unprecedented level of visualization, revealing the intricate layers of the retina and the optic disc with greater clarity and detail than ever before. These and other technologies are refining disease monitoring, providing more accurate measurement, and serving as  improved guides for treatment. 

Demand for retinal treatments is soaring, spurred by rapid growth in elderly populations, increases in diabetes, greater access to medical care in emerging economies, and higher quality-of-life expectations among the aging. New anti-VEGF therapies are successfully treating vision-threatening retinal diseases that, in the recent past, had been largely untreatable. Investigational pharmaceuticals and biologics are making progress in halting the relentless progression of blinding retinal diseases. The retinal treatment paradigm has shifted, and a wealth of new science, business acumen, and bioentrepreneurial activity promise further transformations.

The aging of the global population will lead to steady increases in ophthalmic surgery during the next five years. This and rising concerns over cross-contamination are key factors that will drive growth in the single-use ophthalmic surgical products market during the period. New technologies and products such as refractive IOLs will add to the mix of market drivers, as will the increased demand for labor-saving devices, which has been spurred by a growing shortage of ophthalmologists and nurses.

Market Scope expects the global ophthalmic single-use surgical products market to generate $1.95 billion in revenues in 2009, and we forecast that the market will climb to $2.5 billion by 2014, representing a compounded annual growth rate of 5.1 percent.

An aging global population, rising affluence, and expanded access to eye care plus increased computer use and more effective dry eye products are expected to fuel double-digit compounded growth in the dry eye products market during the next five years.  We expect much of this growth to occur in the pharmaceutical segment where new pipeline therapies are poised to join two very successful commercialized Rx products.

Our yearly report on the global IOL market is the leading industry source for accurate and timely information on intraocular lens markets throughout the world. We use eight geographic/economic categories to examine global markets: the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and the rest of the world. We compile and analyze data on IOL procedure volumes, IOL market shares by technology and manufacturer, and average prices. The data is drawn from our quarterly surveys of ophthalmic surgeons, company financial reporting, interviews with company executives and published clinical data. A five-year market forecast by segment and by geographic region is also included.

Our Comprehensive Report on the Presbyopia-Correcting Surgery Market is the leading industry source for accurate and relevant information on all aspects of the market. In depth coverage is provided on prospective presbyopia surgery patient segments and refractive errors, and also includes analysis of cataract patients, LASIK, post-LASIK and post cataract patients segments. Our report covers of all relevant technologies including multifocal IOLs, accommodating IOLs, multifocal and other laser ablation techniques, corneal inlays, scleral expansion and combination treatment techniques.

The data included in our reports is based on surveys of ophthalmic surgeons, extensive reviews and analysis of clinical data, interviews with company executives and analysis of financial data.

A confluence of rising vision expectations and technological innovations will drive the development of a large market for treatment of presbyopia. This rapidly developing market is still in its infancy with 2008 revenues at the manufacturer level of $307 million, and the market is expected to grow to $1.5 billion by 2013. Much of this market growth will still occur after 2013 as new technologies, which will drive increased demand, reach the market. Procedure volumes of 419 thousand in 2008 are expected to grow to 9.3 million by 2020.

Today, options for treatment of presbyopia remain limited, risks of complications are significant and many compromises are required. Together, these factors currently reduce the value proposition for the surgical correction of presbyopia. Yet some of the products that will serve this evolving market are available today, as well as a growing network of laser centers and surgery centers prepared to offer refractive surgery, a rapidly growing senior population segment with more active and demanding lifestyles and increasing affluence worldwide.

The Comprehensive Report on the Presbyopia-Correcting Surgery Market was published in February 2009 and is printed in color and spiral bound for ease of reading. The price of the report is $3,650; additional copies are available for use within your company for $300 each.

Our report is the leading industry source for accurate and timely information on all aspects of the markets for ophthalmic diagnostic equipment used for primary eye care and for preoperative diagnostic tests. The report includes corneal topographers, comprehensive eye scanners, wavefron analyzers, aberrometers, A-Scan, specular microscopes, refractors, pachymeters, retinoscopes, chart projectors, lensometers, slit lamps, direct ophthalmoscopes and OR microscopes. We feature a review of the technology used, its clinical applications, and a discussion of the competitive environment.

We use eight geographic/economic categories to examine global markets: the US, Western Europe, Japan, other wealthy nations, China, India, Latin America and the rest of the world. We compile and analyze data on the installed base of equipment, market share by technology and manufacturer, unit demand, and prices. The data is drawn from our quarterly surveys of ophthalmic surgeons, company financial reporting, interviews with company executives and published clinical data. Based on our understanding of the industry and our data analysis over time, we provide five-year market forecasts.

Our report offers context for further understanding market trends and forecasts with discussions of ophthalmic specialties, reimbursement issues and eye care worldwide. Our final chapter profiles the companies involved in the surgical and office-based diagnostic equipment markets.

The 2008 Comprehensive Report on the Global Surgical & Office-Based Diagnostic Equipment Market was published in January 2009. This spiral-bound, full-color, 234-page report is chockfull of useful graphs, charts, tables and images of the technology that help bring the text to life and enhance the report’s readability. The price of the report is $3,200. Additional copies are available for use within your company at an additional charge of $300 per copy.